TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03425201 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT03425201 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02493829 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study NCT02445053 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04321421 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02275429 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03049553 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00311987 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00311987 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00352677 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00352677 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00701649 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02923791 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01031368 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02216123 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT04714125 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01475747 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01187381 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01793844 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02092597 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01633762 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT04552821 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT02411396 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02928575 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT02328118 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02328118 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06249074 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT02434757 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01279889 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02952638 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT01346631 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT02597335 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT02597335 — Pharmacodynamic Biomarker (PDY): 2-hydroxyglutarate
Study NCT00003397 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04226989 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02706405 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00266123 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study NCT00847262 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00066677 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03863509 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03863509 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03863509 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02726451 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00603525 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00603525 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03511963 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03856216 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03747120 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03747120 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02912546 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT03852017 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT02009488 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02009488 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01345006 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT01597388 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03088527 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06376578 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02297386 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02484755 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02484755 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01806142 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study NCT02685306 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01493401 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT04407689 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02152306 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00001468 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00001468 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT00532233 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT03172026 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT03558919 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02164331 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03799159 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT03799159 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03799159 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT00872599 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00872599 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03843229 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03843229 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03843229 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT01271725 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03488966 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04542967 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02911233 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00005076 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02122575 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT00185185 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02040857 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04052308 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04052308 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT03385148 — Predictive Biomarker (PRD): PTK7 mRNA
Genes: PTK7; CCK4
Study NCT01850225 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT04459689 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02225093 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT02225093 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00774293 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04342637 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01941329 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01941329 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01941329 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03664830 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02119767 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study NCT03400852 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00376077 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT01408420 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02922023 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00896298 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT00494585 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT00233974 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT03808701 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03535831 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05109949 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT00821847 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT02363738 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03002350 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03002350 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03002350 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00241046 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00395655 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00619047 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04183764 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study NCT02828098 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02650713 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT01383733 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01383733 — Predictive Biomarker (PRD): TNF-related weak inducer of apoptosis
Genes: TNFSF12; APO3L; DR3LG; UNQ181/PRO207
Study NCT04370873 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT04370873 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT02944162 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT01538966 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study NCT04767893 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04767893 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT00792948 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00792948 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00328289 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01504022 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00573742 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00295191 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03170661 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT04211597 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00896766 — Predictive Biomarker (PRD): PPP3CA mRNA
Genes: PPP3CA; CALNA; CNA
Study NCT03221166 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00132366 — Safety Biomarker (SAF): Succinate-semialdehyde dehydrogenase
Genes: ALDH5A1; SSADH
Study NCT03448731 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03448731 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00661141 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study NCT01811550 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT03655353 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03591068 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT00896727 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00896727 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01433796 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03838042 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT02130193 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02199223 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02199223 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT00091039 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT01667432 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03276676 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT01259089 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02269670 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03449901 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study NCT05891808 — Safety Biomarker (SAF): miR-155
Genes: MIR155
Study NCT01840410 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01840410 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04515433 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03921853 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02130323 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00147589 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00213889 — Predictive Biomarker (PRD): TWIST1 mRNA
Genes: TWIST1; BHLHA38; TWIST
Study NCT01088347 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT01088347 — Predictive Biomarker (PRD): TNFRSF10A mRNA
Genes: TNFRSF10A; APO2; DR4; TRAILR1
Study NCT01088347 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02642159 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT02642159 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02642159 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04681157 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04312113 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03907072 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01083251 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02929277 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT02856100 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02401048 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06669481 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03636529 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT03636529 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02907918 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02907918 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT02907918 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00155077 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00155077 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01593787 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03387137 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04423523 — Safety Biomarker (SAF): Human leucocyte antigen
Study NCT01505959 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00140374 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01356875 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT03811899 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01152892 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00817752 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04534608 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02226861 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02083692 — Predictive Biomarker (PRD): TOMM20 mRNA
Genes: TOMM20; KIAA0016
Study NCT02083692 — Predictive Biomarker (PRD): SLC16A4 mRNA
Genes: SLC16A4; MCT4; MCT5
Study NCT01484431 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03527472 — Predictive Biomarker (PRD): GRIN2A mRNA
Genes: GRIN2A; NMDAR2A
Study NCT00306813 — Predictive Biomarker (PRD): RRAD mRNA
Genes: RRAD; RAD
Study NCT02673632 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00623259 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04117204 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01121367 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT03457376 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT04438694 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01865370 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01865370 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01865370 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01423591 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01363570 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01363570 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01363570 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01702558 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00019916 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00019916 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01205594 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03011567 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02296567 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02296567 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04410094 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02897050 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01112397 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01112397 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT00693329 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT00456742 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT00902304 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01531673 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03686228 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01707862 — Predictive Biomarker (PRD): IVL mRNA
Genes: IVL
Study NCT02898272 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01398371 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01387880 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01200212 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02710812 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04323813 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT00567567 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT00100607 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01352923 — Predictive Biomarker (PRD): PEAR1 mRNA
Genes: PEAR1; MEGF12
Study NCT05184530 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03359174 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT02741245 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02401347 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02401347 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT02401347 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02401347 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT00106860 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT03774810 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03451019 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03526653 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03526653 — Safety Biomarker (SAF): BDNF
Study NCT02354534 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00324870 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03836261 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT00285701 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study NCT01523067 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01845480 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01845480 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00005470 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04983459 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00512655 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT01334801 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT01064739 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02586623 — Predictive Biomarker (PRD): DBH mRNA
Genes: DBH
Study NCT03077542 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS